Vyvanse for ADHD: Uses, Side Effects, How Long It Lasts

Vyvanse is one of the most searched ADHD medications in the US, and for good reason. It is long-acting, it has an unusual design, and it is the only ADHD stimulant that also carries an FDA approval for an eating disorder.

A quick word on where I stand. I have ADHD, I was diagnosed at 22, and I live in Turkey, where Vyvanse is not sold. So this is not a story about taking it. It is a research-based explainer built on the FDA label and published studies, written the way I wish someone had explained my own medication to me.

Whether Vyvanse is right for you, and at what dose, is a decision for you and your prescriber. Nothing here replaces that conversation.

What Vyvanse is

Vyvanse is the brand name for lisdexamfetamine dimesylate, made by Takeda. The FDA first approved it in 2007. It belongs to the amphetamine family of stimulants, the same broad group as Adderall, but it is built differently.

According to the current FDA label (revised April 2026), Vyvanse is approved for two conditions:

• ADHD in adults and in children 6 years and older.
• Moderate to severe binge eating disorder (BED) in adults.

It is not recommended for children under 6, and it is not approved for weight loss. It comes as capsules and as chewable tablets in several strengths, and the label says the two forms can be swapped milligram for milligram.

If you want to see where it sits among the other options, the list of ADHD medications lays out the stimulant and non-stimulant families side by side.

How the prodrug design works

This is the part that makes Vyvanse different, so it is worth slowing down.

A prodrug is a medicine that does nothing until the body changes it. Lisdexamfetamine is dextroamphetamine with an amino acid, l-lysine, attached to it. While that lysine is attached, the molecule is inactive.

After you swallow it, the intact molecule is absorbed from the small intestine. Then red blood cells cut the lysine off, and what remains is dextroamphetamine, the part that acts on the brain. Laboratory work by Pennick (2010) found that this conversion happens mainly in whole blood, specifically in red blood cells, and not in the liver or kidneys in any meaningful way. The FDA label says the same, and adds that the drug is not broken down by the CYP450 liver enzymes.

Why does this matter for you?

• The start is gradual. The active drug builds up as red blood cells do their work, so the effect tends to come on smoothly rather than all at once.
• The day is long. Dextroamphetamine has a half-life of roughly 10 to 11 hours in healthy adults, according to the label.
• It is steady. The label reports low variability in blood levels, both between people and for the same person from day to day.

The pill you swallow is not the drug that works. Your blood finishes the job.

How long Vyvanse lasts

This is the question most people type into Google, so here is what the evidence actually shows.

The FDA label describes two studies that measured how long the benefit held up:

• In a classroom study with children, behavior ratings were checked through 13 hours after the morning dose, and Vyvanse beat placebo across those time points.
• In a simulated workplace study with adults, a math performance test was given through 14 hours after the dose, and Vyvanse showed improvement at every time point measured.

That is a study setting, not a promise. In real life, how long it feels like it lasts depends on your body, your dose, your sleep, whether you ate, and what your day asks of you.

On timing, the label gives a few numbers. In children who took a capsule on an empty stomach, dextroamphetamine peaked about 3.5 hours later. A high-fat meal pushed the peak back by about an hour. This is one reason the label says to take Vyvanse in the morning and to avoid afternoon doses: the effect can still be running at bedtime.

For more on the first days and weeks in general, I wrote about how long ADHD medication takes to work.

Vyvanse at a glance

Feature	What the FDA label says
Active ingredient	Lisdexamfetamine dimesylate (converted to dextroamphetamine)
Approved uses	ADHD (age 6 and up), moderate to severe BED (adults)
Forms	Capsules and chewable tablets
When to take	In the morning, with or without food
Opening the capsule	Allowed: mix into yogurt, water or orange juice and take right away
Effect measured in studies	Up to 13 hours (children), up to 14 hours (adults)
Controlled status	Schedule II (CII)
Boxed warning	Abuse, misuse and addiction
Do not combine with	MAO inhibitors, or within 14 days of stopping one

Common side effects

The label lists the side effects that showed up in at least 5% of people on Vyvanse and at least twice as often as on placebo. In ADHD studies these included decreased appetite, insomnia, dry mouth, irritability, anxiety, nausea, diarrhea, upper stomach pain, vomiting, dizziness and weight loss.

Here are the numbers from the adult ADHD study and the binge eating studies, straight from the label:

Side effect	Adults with ADHD (Vyvanse vs placebo)	Adults with BED (Vyvanse vs placebo)
Decreased appetite	27% vs 2%	8% vs 2%
Insomnia	27% vs 8%	20% vs 8%
Dry mouth	26% vs 3%	36% vs 7%
Anxiety	6% vs 0%	5% vs 1%
Feeling jittery	4% vs 0%	6% vs 1%
Increased heart rate	2% vs 0%	7% vs 1%

In children ages 6 to 12, decreased appetite was reported by 39% on Vyvanse compared with 4% on placebo. In the adult ADHD study, 6% stopped Vyvanse because of side effects, compared with 2% on placebo.

Appetite and sleep are the two that come up most, and they deserve their own pages. I wrote about ADHD medication and appetite loss and ADHD medication and sleep. For a broader look at which effects tend to settle and which need a change, see ADHD medication side effects. If you want the full picture for its close cousin, there is also a page on Adderall side effects.

Serious warnings to know about

The label's warnings section covers more than everyday side effects. In plain words, these are the areas it flags:

• Abuse, misuse and addiction. This is the boxed warning, the strongest kind the FDA uses.
• Heart. Stimulants can raise blood pressure and heart rate. People with serious heart problems face higher risks, which is why prescribers ask about heart history. I covered this in ADHD medication and the heart.
• Psychiatric effects. New or worse symptoms such as mania or psychosis are possible, especially in people with a personal or family history.
• Growth in children. Long-term use can slow growth, so height and weight are tracked.
• Circulation. Fingers or toes can turn pale, cold or painful (Raynaud's phenomenon).
• Serotonin syndrome. The risk rises when combined with certain other medications.
• Tics. Vyvanse can bring on or worsen motor and verbal tics.

The label also notes that substances that change urine acidity, like vitamin C or sodium bicarbonate, can change amphetamine levels. This is a good reason to tell your prescriber about every supplement you take.

Is Vyvanse less addictive?

You will often read that the prodrug design makes Vyvanse "harder to abuse." There is a real basis for that, and a real limit.

In a small study, Jasinski and Krishnan (2009) gave adults with a history of stimulant misuse an injected dose of lisdexamfetamine or of immediate-release dextroamphetamine. The dextroamphetamine produced significantly higher "liking" scores than placebo. Lisdexamfetamine did not, at the doses tested. Because the conversion depends on red blood cells, taking the drug in a different way does not skip the slow step.

That said, the FDA still gives Vyvanse the same boxed warning as other stimulants, and it remains Schedule II. A slower design lowers some risks. It does not remove them. I explored the wider question in is ADHD medication addictive.

Vyvanse for binge eating disorder

Vyvanse was the first medication the FDA approved for moderate to severe binge eating disorder in adults. That approval rests on two large phase 3 trials published by McElroy and colleagues (2016), with 383 and 390 adults. In both trials, people on Vyvanse had significantly fewer binge eating days per week by the end of 12 weeks than people on placebo. The most common side effects were dry mouth, insomnia and headache.

Two points often get lost here. First, this approval is for adults only, not children. Second, binge eating disorder is a recognized eating disorder, and treating it is not the same as treating weight. The label is explicit that Vyvanse is not for weight loss.

ADHD and binge eating overlap more than most people realize. I wrote about why in ADHD and binge eating.

How Vyvanse compares with other options

The big network meta-analysis by Cortese and colleagues (2018), which pooled 133 double-blind trials, grouped lisdexamfetamine with the amphetamines. In adults, amphetamines showed the largest effect on clinician-rated symptoms of all the medications studied. The same analysis found that amphetamines also led to more dropouts because of side effects than placebo did, so efficacy and tolerability have to be weighed together.

Compared with mixed amphetamine salts, the main differences are the prodrug design and the smoother curve. I put the details in Vyvanse vs Adderall. If stimulants are not an option for you, non-stimulant ADHD medications work in a different way.

Generic Vyvanse and the shortage

The FDA approved the first generic versions of lisdexamfetamine capsules and chewable tablets in August 2023. They carry the same approved uses and the same boxed warning as the brand. For many people, the generic changes the cost picture a lot, which I look at in ADHD medication without insurance.

Availability is a separate story. When I checked the FDA Drug Shortages database on October 23, 2026, lisdexamfetamine capsules were still listed as currently in shortage, an entry first posted in July 2023. Several generic manufacturers reported all strengths available, while others reported limited supply or supply on allocation. This changes often, so check the database or ask your pharmacy for the current picture. The broader story of stimulant shortages is in the Adderall shortage.

Vyvanse and Elvanse

If you travel or read European forums, you will see the name Elvanse. It is the same active ingredient, lisdexamfetamine, sold under a different brand in the UK and several other European countries.

The rules around it are not identical. In the UK, for example, Elvanse is licensed for children 6 and older whose response to methylphenidate was not enough, and for adults whose symptoms were present in childhood, with treatment supervised by a specialist. If you are moving or traveling with your medication, check the rules of the country you are going to before you pack it.

Before you talk to your prescriber

A few questions can make that appointment more useful:

• Which hours of my day do I most need coverage for?
• How will we judge whether it is working, and after how long?
• What should I watch for with my heart, sleep and mood?
• Are any of my other medications or supplements a problem?

Writing down what you notice during the first weeks makes these conversations much easier. The steps at the top of this page are a simple way to do that.